PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, California, USA.\', \'Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.\', \'Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.\', \'Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.\', \'Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California, USA.\', \'Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.\', \'Department of Neurology, University of California, San Francisco, San Francisco, California, USA.\', \'Division of Infectious Disease, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/acn3.51498
?:doi
?:hasPublicationType
?:journal
  • Annals of clinical and translational neurology
is ?:pmid of
?:pmid
?:pmid
  • 35043593
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.284
?:rankingScore_hIndex
  • 22
?:title
  • Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all